Evidence map›Paper›PMID 36156627›Full record

ArticleSe pu = Chinese journal of chromatography2022

[Determination of the species origin and thrombin-like enzyme content of

Ruiqing Xian, Baojian Hang, Liping Gong, Congcong Wang, Xunjie Zhang, Li Peng, Feng Shi

Open access · greenAbstract read
In one paragraph

Article in Se pu = Chinese journal of chromatography, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ruiqing XianNational Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Genetic Drugs, Shandong Institute for Food and Drug Control, Jinan 250101, China.
Baojian HangNational Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Genetic Drugs, Shandong Institute for Food and Drug Control, Jinan 250101, China.
Liping GongNational Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Genetic Drugs, Shandong Institute for Food and Drug Control, Jinan 250101, China.
Congcong WangNational Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Genetic Drugs, Shandong Institute for Food and Drug Control, Jinan 250101, China.
Xunjie ZhangNational Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Genetic Drugs, Shandong Institute for Food and Drug Control, Jinan 250101, China.
Li PengDepartment of Quality Control, China Resources Double-Crane Limin Pharmaceutical (Jinan) Co., Ltd., Jinan 250200, China.
Feng ShiNational Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Genetic Drugs, Shandong Institute for Food and Drug Control, Jinan 250101, China.
Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Snake venom thrombin drugs are hemostatic drugs prepared from

Indexed as

BothropsHemostaticsAcetonitrilesAnimalsBatroxobinChromatography, High Pressure LiquidPeptide FragmentsPeptidesProteomeSnake VenomsTandem Mass SpectrometryThrombinTrypsinWaterAcetonitrilesBatroxobinHemostaticsPeptide FragmentsPeptidesProteomeSnake VenomsThrombinTrypsinWatermarker peptidesnake venomsnake venom thrombin-like enzymes (svTLEs)ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS)

Identifiers

PMID36156627
PMCPMC9520370
OpenAlexW4297107780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.